Genome-wide association study of restless legs syndrome in end-stage renal disease

Résumé fourni par la source

Abstract Study Objectives Restless legs syndrome (RLS) is predominantly idiopathic (iRLS), with a prevalence of 2-10% in Europe. In end-stage renal disease patients (ESRD), uremic RLS (uRLS) is substantially more prevalent, with estimates of 24–28%. Its pathophysiology has not been fully uncovered. Therefore, we investigated potential genetic and phenotypic risk factors for uRLS. Methods We performed case-control genome-wide association studies (GWAS) on ESRD patients with and without RLS from two German and one Greek ESRD study populations (cases/controls: 186/356, 80/176, 134/357). We applied a polygenic risk score (PRS) for iRLS to four groups: uRLS cases, uremic controls, a group of iRLS cases and European 1000G individuals. Additionally, we investigated RLS associations with phenotype data available in one German dataset. Results No SNP reached genome-wide significance in any single dataset or meta-analyses. The mean iRLS PRS was significantly higher in uRLS cases compared to uremic controls (p=9.47e-10) and European 1000G individuals (p=9.93e-6) and significantly smaller compared to iRLS cases (p=4.84e-5). Among 164 available lead SNPs at known RLS risk loci, rs113851554 at the MEIS1 locus, the strongest known iRLS-associated variant, was significant after Bonferroni correction (0.05/164=3.05e-4) in the German uremic meta-analysis (p=5.73e-5). Two loci rs36127502 and rs5769388, previously not associated with RLS, show suggestive significance (p=1.37e-7, p=1.92e-7) in a meta-analysis combining the three GWAS datasets. Regular smoking and parathormone levels were nominally associated with RLS in ESRD. Conclusions Our findings indicate that uRLS and iRLS share a substantial part of their genetic architecture, while also pointing to candidate signals specific to uRLS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.